MyFinsight
Home
Blog
About
Net loss
$30,000K
Proceeds from issuance of
convertible notes - related...
$9,700K
Purchases of property and
equipment
-$196K
(-200.00%↓ Y/Y)
Proceeds from sale of
property and equipment
$102K
(750.00%↑ Y/Y)
Genefab sublease
deferred income - related...
$2,295K
Operating lease
liabilities
$699K
Accounts
receivable-Related Party
-$666K
Prepaid expenses and
other...
-$402K
Accounts
receivable-Nonrelated Party
-$311K
Convertible note issuance
costs included in net...
$300K
Other non-cash
charges
$13K
(-66.67%↓ Y/Y)
Payment of issuance
costs
-$2,444K
(-199.47%↓ Y/Y)
Net cash used in
operating activities
$14,839K
(154.71%↑ Y/Y)
Net cash provided by
financing activities
$8,836K
(1380.07%↑ Y/Y)
Net cash provided by
(used in) investing...
$298K
(261.96%↑ Y/Y)
Canceled cashflow
$19,847K
Canceled cashflow
$3,308K
Net decrease in
cash, cash...
$23,973K
(189.75%↑ Y/Y)
Gain on lease
modification
$6,762K
Prepaid expenses and
other assets-Related...
$5,901K
Stock-based compensation
-$1,918K
(-170.26%↓ Y/Y)
Accrued expenses and
other current...
-$1,580K
Depreciation
-$1,389K
(-175.49%↓ Y/Y)
Accounts payable
-$1,240K
Operating lease
right-of-use assets
$655K
Gain on change in fair
value of convertible...
$271K
Other non-current
liabilities
$99K
Deferred revenue -
related party
-$32K
Proceeds from cirm grant
-$2,520K
(-200.00%↓ Y/Y)
something is missing
-$670K
Taxes paid related to
net settlement of...
$118K
Back
Back
Cash Flow
Senti Biosciences Holdings, Inc. (SNTI)
Senti Biosciences Holdings, Inc. (SNTI)
source: myfinsight.com